A detailed history of Marshall Wace, LLP transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 2,494,584 shares of EBS stock, worth $20.3 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,494,584
Previous 542,813 359.57%
Holding current value
$20.3 Million
Previous $3.7 Million 462.79%
% of portfolio
0.03%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.72 - $14.77 $11.2 Million - $28.8 Million
1,951,771 Added 359.57%
2,494,584 $20.8 Million
Q2 2024

Aug 14, 2024

BUY
$1.86 - $6.98 $434,014 - $1.63 Million
233,341 Added 75.4%
542,813 $3.7 Million
Q1 2024

May 15, 2024

BUY
$1.5 - $3.41 $346,941 - $788,712
231,294 Added 295.86%
309,472 $782,000
Q4 2023

Feb 14, 2024

SELL
$1.82 - $3.16 $148,515 - $257,862
-81,602 Reduced 51.07%
78,178 $187,000
Q3 2023

Nov 14, 2023

SELL
$3.17 - $7.91 $81,735 - $203,951
-25,784 Reduced 13.89%
159,780 $543,000
Q2 2023

Aug 14, 2023

BUY
$7.35 - $13.21 $1.28 Million - $2.29 Million
173,732 Added 1468.32%
185,564 $1.36 Million
Q1 2023

May 15, 2023

BUY
$7.79 - $16.29 $92,171 - $192,743
11,832 New
11,832 $122,000
Q2 2022

Aug 15, 2022

BUY
$27.42 - $43.63 $12.3 Million - $19.6 Million
448,533 New
448,533 $13.9 Million
Q1 2022

May 16, 2022

SELL
$36.48 - $52.22 $748,533 - $1.07 Million
-20,519 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$33.11 - $55.01 $3.38 Million - $5.62 Million
-102,200 Reduced 83.28%
20,519 $893,000
Q3 2021

Nov 15, 2021

BUY
$50.07 - $66.05 $565,590 - $746,100
11,296 Added 10.14%
122,719 $6.15 Million
Q2 2021

Aug 13, 2021

BUY
$56.61 - $80.46 $6.31 Million - $8.97 Million
111,423 New
111,423 $7.02 Million
Q1 2020

May 15, 2020

SELL
$49.34 - $68.76 $8.09 Million - $11.3 Million
-163,975 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$51.21 - $59.06 $6.67 Million - $7.69 Million
-130,267 Reduced 44.27%
163,975 $8.85 Million
Q3 2019

Nov 14, 2019

BUY
$40.6 - $57.2 $8.89 Million - $12.5 Million
218,936 Added 290.73%
294,242 $15.4 Million
Q2 2019

Aug 14, 2019

BUY
$39.92 - $53.86 $3.01 Million - $4.06 Million
75,306 New
75,306 $3.64 Million

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $406M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.